India to Jordan: Cetuximab Export Trade Route

The India to Jordan Cetuximab corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $20.6K USD. The route is dominated by DOSHI MEDICARE PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's cetuximab manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $20.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with cetuximab's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 28.2%, placing it at rank #12 among India's top cetuximab export destinations globally.

On the import side, key buyers of Indian cetuximab in Jordan include TO THE ORDER OF ,. TO THE ORDER OF , is the single largest importer with 1 shipments valued at $20.6K USD.

India's cetuximab exports to Jordan are driven primarily by a handful of large-scale manufacturers. DOSHI MEDICARE PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Jordan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DOSHI MEDICARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $20.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, TO THE ORDER OF , is the largest importer with 1 shipments worth $20.6K USD — representing 100% of all cetuximab imports from India on this route.